chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 102 F; Headache lasted a day; Dose 3; Body aches; Chills; Pain in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Dec2021 18:45 (Lot number: FI8757) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Birth control" (ongoing). Concomitant medication(s) included: YASMIN taken for contraception (ongoing). Vaccination history included: Bnt162b2 (Dose: 1, Time: 9:57 am, Anatomical site of injection: Left Arm, Route of administration: Intramuscular, Batch/lot number: EW0161), administration date: 18Apr2021, when the patient was 35 years old, for COVID-19 immunization, reaction(s): "Skin rash/all over body skin rash"; Bnt162b2 (Dose: 2, Time: 10:13 am, Anatomical site of injection: Left Arm, Batch/lot number: EW0183), administration date: 09May2021, when the patient was 35 years old, for COVID-19 immunization, reaction(s): "High fever (above 103F)/fever of 103.1", "Body aches", "Chills", "Measles likes rashes".  The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021 18:45, outcome "unknown", described as "Dose 3"; PYREXIA (non-serious) with onset 10Dec2021 06:45, outcome "recovered" (11Dec2021), described as "Fever of 102 F"; HEADACHE (non-serious) with onset 10Dec2021 06:45, outcome "recovered" (Dec2021), described as "Headache lasted a day"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "Body aches"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "Chills"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "Pain in the arm". The events "fever of 102 f" and "headache lasted a day" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, headache.  Additional information: It was reported that after dose 3 the patient had fever of 102 F. It started 12h after the 3rd dose. It persisted for 1 day. The patient did not take any Tylenol. Also headache, lasted a day. She was experiencing headache after covid vaccine, Other effects included body ache, chills and pain in the arm. Prior vaccination within 4 weeks was none.   Follow-up attempts are completed. No further information is expected.
Almost immediately felt swelling at the injection site, which I felt as being normal.  Next day when I woke up felt a slight headache , abnormal vision issues that included sparkles, blurred vision and a general tiredness. Did not feel refreshed as I normally do when I wake up in the morning. As the day went on sparkles and vision issues remained and headache got worse. Went to bed earlier than normal and next day when woke up the symptoms got worse, I felt like I had a migraine. Vision issues persisted. Laid down around 11AM and took a nap and when I woke up I noticed a blotch in my left eye reminiscent of the shape of a fish (looked like a shark) and it had different colors. Bright yellow and black almost kind of an iridescent green and orange. The shape was still just the colors were different.  I panicked and called the optometrist and explained what happened. They wanted to see me right away. I was able to be seen in the afternoon. They looked at it, did two tests and came with the diagnosis of a branch retinal artery occlusion.  I visited my neuro- ophthalmologist on 01/28 and he confirmed the diagnosis had previously given.  He then ordered fedrate and a couple of other tests. They also did a visual acuity in the left eye (20/30) and color vision (8/8 normal) and color plates and intraocular pressure (16 OS)
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 20-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Jan2022 12:00 (Lot number: 33025BD) at the age of 20 years as dose 2 (booster), single for Covid-19 immunisation. Relevant medical history included: "Johnson & Johnson Dose Number: 1", start date: 20Jan2022 (unspecified if ongoing), notes: Verbatim: Johnson & Johnson Dose Number: 1. The patient's concomitant medications were not reported. Vaccination history included: Johnson & Johnson (Dose Number: 1, Batch/Lot No: 201A21A, Location of injection: Arm Left, Vaccine Administration Time: 03:45 PM), administration date: 09Apr2021, when the patient was 20 years old, for COVID-19 immunization. The following information was reported: COUGH (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Coughing"; ABDOMINAL PAIN (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Abdominal Pain"; CHEST PAIN (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Chest pain"; HYPERTENSION (medically significant), HEART RATE INCREASED (medically significant) all with onset 20Jan2022 18:30, outcome "not recovered" and all described as "High BP and HR"; HEADACHE (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Headache"; BACK PAIN (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Back pain"; PALPITATIONS (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Palpitations"; INSOMNIA (medically significant) with onset 20Jan2022 18:30, outcome "not recovered", described as "Insomnia because of the pain". The events "coughing", "abdominal pain", "chest pain", "high BP and HR", "high BP and HR", "headache", "back pain", "palpitations" and "insomnia because of the pain" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (20Jan2022) high; heart rate: (20Jan2022) high. Therapeutic measures were taken as a result of cough, abdominal pain, chest pain, hypertension, heart rate increased, headache, back pain, palpitations, insomnia. Clinical Course: The patient experienced coughing, Abdominal Pain, Chest pain, high BP and HR, headache, back pain, palpitations, and insomnia because of the pain. AE treatment included Tylenol and Ibuprofen. No other vaccine in four weeks. No Covid prior vaccination and no Covid tested post vaccination.
This is a spontaneous report received from a noncontactable consumer or other non-HCP (parent). A male patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed a headache/he had a very severe headache/migraine, with outcome of not recovered. The events evaluated at an emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient received the Pfizer vaccine and since then he experienced a very severe headache/severe migraine. It's 24/7. It doesn't go away. He had CT scan and MRI; but still no improvement. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Neck Pain; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck Pain) and FATIGUE (Tiredness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck Pain) and FATIGUE (Tiredness). At the time of the report, NECK PAIN (Neck Pain) and FATIGUE (Tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.   This case was linked to MOD-2021-086154 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-MAY-2021 updated event outcome to recovered.
Woke on the morning of 1/10/21 (about 30 hours after injection).  Temp to 100.6F, mild chills, major joints ache, dry cough, runny nose/eyes.  Felt a bit better after Motrin400mg,  but symptoms returned, although now worse the original presentation so far.
This spontaneous report as received from a clinical medical assistant (CMA) refers to a 8 week old patient. On 02-APR-2014 the patient was vaccinated with expired ROTATEQ (lot # H015715, expired date 15-MAR-2014) as the first dose of ROTATEQ. No adverse effect reported. Additional information is not expected.
The evening of receiving the vaccine she experienced itching eyes.  The next morning her rt eye was swollen and she had red spots on face and forehead.   Her arm was swollen and she experienced a knot at the injection site.
I stayed 30 minutes after and I was good to go and went home. Within 6 hours I felt fatigued and had chills and a low grade fever. My arm started getting sore. I had similar symptoms to first dose but much more severe. I went to bed and I started running a 102 fever and had restless legs and cramps in my feet, legs, and hands. When I would hold my hand upwards my fingers would curl to my wrists and I couldn't expand my fingers outwards and that lasted on and off. I had severe joint pain and muscle pain and it wasn't the same was when I had the flu. That lasted for 3 days. I also had trouble sleeping. Tylenol was helpful and I took that after receiving my 2nd dose within 24 hours. I felt very nauseous but never got sick or anything. I called my PCP and she said that basically there wasn't anything much she could do and just to treat symptoms. By the 3rd day it was like a light switch.
About 2 days after the second dose I started to have neuropathy in my feet.  It is worse in my right foot.  It has lasted now for over 7 months.  I have reprted it to Pfizer and the Hospital.  All the hospital precribes is paracetimol and naproxen..  Neither one has a perceivable affect on it.
This spontaneous report was received from a pharmacy technician, refers to multiple unspecified patients of unknown ages and genders. Concurrent condition and medical history were not reported. On an unknown date, the patients were vaccinated with a dose improperly stored of GARDASIL lot # K006960, expiration date 10-MAY-2017 and lot # K006960, expiration date in February 2017, also reported as 29-FEB-2017 (strength, dose #, dose, route of administration, anatomical location were not reported). There was not a product quality complaint (PQC) involved. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
she was fully vaccinated with the Pfizer BioNtech covid 19 vaccines in March and April of last year. She now has the covid 19 infection; she was fully vaccinated with the Pfizer BioNtech covid 19 vaccines in March and April of last year. She now has the covid 19 infection; This is a spontaneous report received from a non-contactable consumer or other non hcp. A 66-years-old female patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on Apr2020 ,at the age of 66 years old,as Dose 2,single and dose 1 via an unspecified route of administration on Mar2020 (Batch/Lot number was not reported) as Dose 1,single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced after she was fully vaccinated with the pfizer biontech covid 19 vaccines in march and april of last year she now has the covid 19 infection on an unspecified date. The patient wanted to know if not feeling cold would have impacted the efficacy of vaccine. The outcome of the event was unknown.  No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient c/o slight swelling at injection site the evening after receiving influenza vaccination along with itchiness on subsequent days. Skin at left deltoid noted to have slight discoloration/bruising and very minimal swelling; skin intact and smooth to touch. No warmness or redness noted. Patient denies any hives, wheezing, shortness of breath.
throat hurt; running a fever of 102; tired; This case was reported by a consumer via interactive digital media and described the occurrence of sore throat in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th September 2020 10:00, the patient received the 2nd dose of Shingrix. On 8th September 2020, less than a day after receiving Shingrix, the patient experienced sore throat. In September 2020, the patient experienced fever and tiredness. On an unknown date, the outcome of the sore throat, fever and tiredness were recovered/resolved.   It was unknown if the reporter considered the sore throat, fever and tiredness to be related to Shingrix.  Additional details were provided as follows: the case was reported by the mother of the patient. The age at vaccination was not reported but it could be 52 years or 53 years. The patient received 2nd Shingrix shot at 10:00 a.m. The patient was fine until dinnertime and then patient experienced throat hurt all the way to her Stomach. The patient was running a fever of 102 and was tired for almost 24 hours later.
SHAKING; BODY ACHE; CHILLS; FEVER; HEADACHE; This spontaneous report received from a consumer concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,, and batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced body ache. On 26-MAR-2021, the subject experienced chills. On 26-MAR-2021, the subject experienced fever. On 26-MAR-2021, the subject experienced headache. On 26-Mar-2021, the subject experienced shaking. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shaking, body ache, chills, fever, and headache on 26-MAR-2021. This report was non-serious. This case, from the same reporter is linked.
Patient states that 2 days post vaccine, he developed a red, itchy rash. No fever, no pain. Rash was at injection site about 1 1/2 in diameter.
Mild soreness at injection site; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 13:30 (Lot number: EN6202) at the age of 40 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Mild soreness at injection site". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: The patient did not receive any treatment or any covid vaccine prior vaccination and had no known allergies.  No follow-up attempts are possible. No further information is expected.
Consistent pain in the chest area around two days after 2nd shot- light shortness of breath .  Pain became severe May 10th - Saw my doctor and was sent to the emergency room.  Diagnosis was Pericarditis
On 01/06/21 increased "pounding" heart rate started within minutes of vaccine administration.  01/06 at 08:03 am: BP= 143/86, HR= 72, O2 sats= 96% RA; at 08:12 am:  BP= 130/83, HR= 68, O2 sats= 97% RA; at 08:20 am:  BP= 141/80, HR= 61, O2 sats= 96% RA; 08:30 am:  BP= 129/83, HR= 68, O2 sats= 97% RA
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient felt light-headed about 5 minutes after vaccine and then fainted. She was responsive again almost immediately, but we called 911 to have her checked out before she left. She did not require further care. EMS advised parent to get her to urgent care if that happens again. She does have history of fainting after dental procedure, also.
Nausea; vomiting; Headache; Tinnitus; Weakness; lassitude; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 21Mar2021 at 14:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to opiates (intolerance to opiates). The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 00:30, the patient experienced nausea, vomiting that lasted for several hours, headache lasted until following morning, tinnitus, weakness and lassitude lasted approximately for 24 hours. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, vomiting, headache, tinnitus, weakness and lassitude were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
On Feb 21, fever of 101 discomfort in arm, extreme tiredness. Difficulty sleeping. On February 22, fever of 99.1 , increased redness, heat, and swelling at site (about the size of my palm). Iced site for about an hour and took citirezine antihistamine.  Feb 23, today AM temp 98.6, perhaps size of swelling has decreased. Still painful to raise arm there. Can do all household activities.
Erythema (2 x 2 1/2 in diameter) at Varivax injection site.  Observe - improving by 3/14/08.
Soreness at injection site for 72 hours.; Low grade fever 99.6 orally on day 3.; GI upset for 3 days; Migraine headache  on day 6.; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231; expiry date: unknown) via an unspecified route of administration in the right arm, on 30Dec2020 at 11:00 A.M., at a single dose, for COVID-19 immunization. Relevant medical history included high blood pressure (BP), seasonal allergies, migraine, asthma, right sided hearing loss. The patient was taking unspecified concomitant medications. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 01Jan2021, at 8:00 A.M., the patient experienced soreness at injection site for 72 hours. On day 3, the patient had low grade fever 99.6. On an unspecified date in Jan2021, the patient had gastrointestinal (GI) upset for 3 days. On day 6, the patient experienced migraine headache. The patient did not receive therapy for the events. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 in 01/2023. I contacted my doctor and got a prescription for Paxlovid. I also had tendinitis in both shoulders and buttocks, so I was put on steroids to relieve my symptoms. That worked until I stopped and then I got a cortisone shot. Since that shot, I am feeling better.
Patient experienced hives, swelling, rash at injection site which required an ER visit the day following vaccine administration. FLUZONE HIGH DOSE.
swollen arm; red; hot; hard; tenderness; sore; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (hard) and TENDERNESS (tenderness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (hard), TENDERNESS (tenderness), VACCINATION SITE PAIN (sore) and HEADACHE (headaches). At the time of the report, PERIPHERAL SWELLING (swollen arm), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE WARMTH (hot), VACCINATION SITE INDURATION (hard), TENDERNESS (tenderness), VACCINATION SITE PAIN (sore) and HEADACHE (headaches) outcome was unknown.            No treatment medications were provided. No concomitant medications were reported.
Pt C/O rashes on her arm, soreness and numbness on the arm radiates to the tip of her fingers started last night. Advised to move around her arms.
one of four pt to devel fever of 101 to 102 deg, uncontrollable irritability and a local rxn after rcv vax
1 or 2 weeks after getting the vaccine I developed a lump at the injection site. It does not hurt. The dermatologist looked at it and he had no idea of what it was. He told me to rub some cortisone on it. Nothing happened. I still have it months later. I just have not been to the doctor yet. He said the next step would be to aspirate it.
fall, dizziness, abrasions due to fall, multiple contusions, closed nondisplaced fracture of greater tuberosity of left humerus
The patient received the vaccine and was completely fine. About 10 minutes after giving the vaccine I heard "all store responders report to front lobby" and saw that the patient fell and hit her head and was bleeding from the back of her head. She stated she may have been a bit dizzy, but also said she likely tripped over a mat.
"I can't breathe."  Removed face mask.  Pulse 120.  BP 140/80.  100% pulse ox.  Underlying cardiac issue, so medics transported to hospital.